Jefferies Group LLC Reiterates “Buy” Rating for Organovo Holdings, Inc. (ONVO)
Organovo Holdings, Inc. (NASDAQ:ONVO)‘s stock had its “buy” rating reissued by research analysts at Jefferies Group LLC in a report issued on Thursday. They presently have a $4.00 target price on the stock. Jefferies Group LLC’s target price points to a potential upside of 76.99% from the stock’s current price.
A number of other analysts have also recently weighed in on the stock. ValuEngine cut shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. BidaskClub cut shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 25th. Finally, Evercore ISI restated an “outperform” rating and set a $3.75 target price (down from $4.00) on shares of Organovo Holdings in a report on Friday, June 9th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $6.20.
Shares of Organovo Holdings (NASDAQ ONVO) traded down 3.42% on Thursday, hitting $2.26. The company had a trading volume of 686,998 shares. The stock’s market cap is $239.84 million. The company has a 50-day moving average of $2.11 and a 200 day moving average of $2.64. Organovo Holdings has a 12 month low of $1.75 and a 12 month high of $4.21.
Organovo Holdings (NASDAQ:ONVO) last issued its earnings results on Wednesday, August 9th. The company reported ($0.10) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.10). The firm had revenue of $0.99 million during the quarter, compared to analysts’ expectations of $0.92 million. Organovo Holdings had a negative net margin of 918.97% and a negative return on equity of 65.49%. The firm’s revenue was up 11.1% compared to the same quarter last year. Analysts anticipate that Organovo Holdings will post ($0.39) EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Jefferies Group LLC Reiterates “Buy” Rating for Organovo Holdings, Inc. (ONVO)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/14/jefferies-group-llc-reiterates-buy-rating-for-organovo-holdings-inc-onvo.html.
Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Organovo Holdings by 8.5% in the 1st quarter. Vanguard Group Inc. now owns 4,250,017 shares of the company’s stock worth $13,515,000 after purchasing an additional 333,034 shares during the period. Meridian Wealth Management LLC acquired a new position in Organovo Holdings in the 1st quarter worth approximately $321,000. Metropolitan Life Insurance Co. NY boosted its stake in Organovo Holdings by 15.0% in the 1st quarter. Metropolitan Life Insurance Co. NY now owns 68,487 shares of the company’s stock worth $218,000 after purchasing an additional 8,958 shares during the period. KCG Holdings Inc. boosted its stake in Organovo Holdings by 139.3% in the 1st quarter. KCG Holdings Inc. now owns 144,501 shares of the company’s stock worth $460,000 after purchasing an additional 84,126 shares during the period. Finally, Edmond DE Rothschild Holding S.A. boosted its stake in Organovo Holdings by 191.7% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 35,000 shares of the company’s stock worth $111,000 after purchasing an additional 23,000 shares during the period. 23.94% of the stock is owned by hedge funds and other institutional investors.
Organovo Holdings Company Profile
Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.